Crabb, Simon
Wickens, Robin
Jane-Bibby, Sarah
Dunkley, Denise
Lawrence, Megan
Knight, Allen
Jones, Robert
Birtle, Alison
Huddart, Robert
Linch, Mark
Martin, Jonathan
Coleman, Adam
Boukas, Konstantinos
Markham, Hannah
Griffiths, Gareth
Article History
Received: 21 July 2023
Accepted: 12 September 2023
First Online: 19 September 2023
Declarations
:
: The trial is being performed in accordance with the World Medical Association Declaration of Helsinki. The study received ethical approval from London-Chelsea Research Ethics Committee on 24-May-2022 (ref: 22/LO/0272) and the Health Research Authority (ref: IRAS 1004493). Written informed consent for participation and publication of the participants/patients’ data will be obtained from the participants.
: Not applicable.
: Prof Simon Crabb: received fees for either speaking or advisory work from Roche, Janssen Cilag, MSD, Astellas, Pfizer and Bayer and research support from Roche, AstraZeneca, Astex Pharmaceuticals and Clovis Oncology.Prof Alison Birtle: Ad boards and consultancy fees for Roche/MSD, Merck Pfizer, Astellas, BMS, Janssen.No other competing interests were disclosed.